# Mendus - kliinisen vaiheen bioteknologiayritys

**URL:** https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274
**Category:** Osakkeet
**Tags:** ulkomaiset-osakkeet, immun, mendus
**Created:** [Heinäkuu 23, 2024, 7.30pm UTC](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274 "2024-07-23T19:30:20Z")
**Posts on this page:** 1
**Showing post:** 10

<div class="post-metadata">

### Author: ![Clark\_kent](https://forum.inderes.com/letter_avatar_proxy/v4/letter/c/0ea827/32.png) [@Clark\_kent](https://forum.inderes.com/u/Clark_kent)
#### Post date: [Toukokuu 5, 2025, 12.38pm UTC](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274/10 "2025-05-05T12:38:50Z")

</div>

> **[Mendus AB (publ): Mendus strengthens late-stage clinical developmen...](https://mfn.se/a/mendus/mendus-strengthens-late-stage-clinical-development-ability-and-appoints-dr-tariq-mughal-as-chief-medical-officer)**
>
> Mendus AB ('Mendus' publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced the appointment of Tariq Mughal, MD FRCP FRCPath, as Chief Me...

Kovan tason rekry CMO:ksi Osake +22%

---

_[View the full topic](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274)._